clock menu more-arrow no yes

Filed under:

GOED appoints 3 industry consultants to oversee strategic growth

SALT LAKE CITY — The Governor’s Office of Economic Development has appointed three industry consultants to oversee strategic growth in the aerospace, financial services and life science sectors.

Marshall Wright will serve as director of the aerospace industry cluster, Kelvin Anderson will serve as director of financial services, and Andrew Laver will serve as director of life sciences.

In this new role, each industry consultant will support industry trade groups and convene stakeholders to develop workable solutions. They will work on a part-time contractual basis so they can remain involved in their respective fields full-time, providing insight on the challenges facing each industry.

Wright has more than 45 years’ experience in engineering, marketing and business management in the aerospace and defense industry, working with the U.S. Navy and L-3 Communications, among other organizations. Wright is especially involved in the unmanned systems community and was particularly instrumental in helping Utah open its Aerospace States Association chapter earlier this year.

Prior to his new appointment, Anderson was the president and CEO of Optum Bank. He has been involved in the startup of several industrial banks over the past 28 years. He has served as chairman of the Utah Bankers Association, president of the Utah Association of Financial Services and director of the National Association of Industrial Bankers. He currently serves on the advisory board of the Center for Innovation in Banking and Financial Services.

Laver is managing director of APL Capital Advisors and has made life science his area of funding expertise for more than 20 years. Holding degrees in business administration and bioengineering, his career experience spans a variety of positions in engineering, venture capital, private equity and investment banking. He was also a co-founder of Salt Lake Life Science Angels, an angel investment group focused on seed-stage medical investments.